Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours

  • Sara Costa-Cabral,
  • Rachel Brough,
  • Asha Konde,
  • Marieke Aarts,
  • James Campbell,
  • Eliana Marinari,
  • Jenna Riffell,
  • Alberto Bardelli,
  • Christopher Torrance,
  • Christopher J. Lord,
  • Alan Ashworth

Correction

26 Oct 2018: Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, et al. (2018) Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLOS ONE 13(10): e0206729. https://doi.org/10.1371/journal.pone.0206729 View correction

The affiliation for the eighth author is incorrect. Alberto Bartelli is not affiliated with #3 but with #1 The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, SW3 6JB, United Kingdom and #2 Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, United Kingdom.

Reference

  1. 1. Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2016) CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 11(2): e0149099. pmid:26881434

Citation: Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2017) Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 12(4): e0176578. https://doi.org/10.1371/journal.pone.0176578

Published: April 20, 2017

Copyright: © 2017 Costa-Cabral et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.